The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation
Open accessAbstract
The syndecan family of transmembrane heparan sulfate proteoglycans is abundant on the surface of all adherent mammalian cells. Syndecans bind and modify the action of various growth factors/cytokines, proteases/antiproteases, cell adhesion molecules, and extracellular matrix components. Syndecan expression is highly regulated during wound repair, a process orchestrated by many of these effectors. Each syndecan ectodomain is shed constitutively by cultured cells, but the mechanism and significance of this shedding are not understood. Therefore, we examined (i) whether physiological agents active during wound repair influence syndecan shedding, and (ii) whether wound fluids contain shed syndecan ectodomains.Using SVEC4–10 endothelial cells we find that certain proteases and growth factors accelerate shedding of the syndecan-1 and -4 ectodomains. Protease-accelerated shedding is completely inhibited by serum-containing media. Thrombin activity is duplicated by the 14-amino acid thrombin receptor agonist peptide that directly activates the thrombin receptor and is not inhibited by serum. Epidermal growth factor family members accelerate shedding but FGF-2, platelet-derived growth factor-AB, transforming growth factor-β, tumor necrosis factor-α, and vascular endothelial cell growth factor 165 do not. Shed ectodomains are soluble, stable in the conditioned medium, have the same size core proteins regardless whether shed at a basal rate, or accelerated by thrombin or epidermal growth factor-family members and are found in acute human dermal wound fluids. Thus, shedding is accelerated by activation of at least two distinct receptor classes, G protein-coupled (thrombin) and protein tyrosine kinase (epidermal growth factor). Proteases and growth factors active during wound repair can accelerate syndecan shedding from cell surfaces. Regulated shedding of syndecans suggests physiological roles for the soluble proteoglycan ectodomains. The syndecan family of transmembrane heparan sulfate proteoglycans is abundant on the surface of all adherent mammalian cells. Syndecans bind and modify the action of various growth factors/cytokines, proteases/antiproteases, cell adhesion molecules, and extracellular matrix components. Syndecan expression is highly regulated during wound repair, a process orchestrated by many of these effectors. Each syndecan ectodomain is shed constitutively by cultured cells, but the mechanism and significance of this shedding are not understood. Therefore, we examined (i) whether physiological agents active during wound repair influence syndecan shedding, and (ii) whether wound fluids contain shed syndecan ectodomains. Using SVEC4–10 endothelial cells we find that certain proteases and growth factors accelerate shedding of the syndecan-1 and -4 ectodomains. Protease-accelerated shedding is completely inhibited by serum-containing media. Thrombin activity is duplicated by the 14-amino acid thrombin receptor agonist peptide that directly activates the thrombin receptor and is not inhibited by serum. Epidermal growth factor family members accelerate shedding but FGF-2, platelet-derived growth factor-AB, transforming growth factor-β, tumor necrosis factor-α, and vascular endothelial cell growth factor 165 do not. Shed ectodomains are soluble, stable in the conditioned medium, have the same size core proteins regardless whether shed at a basal rate, or accelerated by thrombin or epidermal growth factor-family members and are found in acute human dermal wound fluids. Thus, shedding is accelerated by activation of at least two distinct receptor classes, G protein-coupled (thrombin) and protein tyrosine kinase (epidermal growth factor). Proteases and growth factors active during wound repair can accelerate syndecan shedding from cell surfaces. Regulated shedding of syndecans suggests physiological roles for the soluble proteoglycan ectodomains. The response to tissue injury is orchestrated by multiple soluble effectors. These are derived from the blood plasma, immigrant cells from the circulation and resident cells at the wound site, and include proteases, antiproteases, growth factors, cytokines, and chemokines (1Bourin M.C. Lindahl U. Biochem. J. 1993; 289: 313-330Google Scholar). Heparin modifies the action of several of these effector molecules such as thrombin, antithrombin III, heparin-binding epidermal growth factor-like growth factor (HB-EGF), 1The abbreviations used are: HB-EGF, heparin-binding epidermal growth factor-like growth factor; EGF, epidermal growth factor; FGF-2, fibroblast growth factor-2; TGF-α, transforming growth factor-α; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α; FCS, fetal calf serum; GAG, glycosaminoglycan; PMA, phorbol 12-myristate 13-acetate; TRAP, thrombin receptor agonist peptide; TPCK,l-1-tosylamido-2-phenylethyl chloromethyl ketone; CM, conditioned medium; HSE-1, serum antibody against human syndecan-1 ectodomain; AU, absorbance unit(s); PAGE, polyac
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
The Molecular and Cellular Biology of Wound Repair
(1988) · Springer eBooks · doi:10.1007/978-1-4615-1795-5 · Cited by 1,516
Growth factor signaling by receptor tyrosine kinases
Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,430
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans
Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., & Lose, E. J. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002053 · Cited by 1,097
Self-citationSoluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9
Wysocki, A. B., Staiano-Coico, L., & Grinnell, F. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12359590 · Cited by 732
The molecular and cellular biology of wound repair
Naylor, I. (1996) · British Journal of Plastic Surgery · doi:10.1016/s0007-1226(96)90047-8 · Cited by 667
MEMBRANE-ANCHORED GROWTH FACTORS
Massagué, J., & Pandiella, A. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002503 · Cited by 660
Pigott, R., Dillon, L. P., Hemingway, I. H., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 649
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torranee, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., et al. (1994) · Nature · doi:10.1038/370218a0 · Cited by 588
Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
McGeehan, G. M., Becherer, J. D., Bast, R. C., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., et al. (1994) · Nature · doi:10.1038/370558a0 · Cited by 561
Molecular cloning of syndecan, an integral membrane proteoglycan.
Saunders, S., Jalkanen, M., O'Farrell, S., & Bernfield, M. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.4.1547 · Cited by 508
Self-citationKim, C. W., Goldberger, O. A., Gallo, R. L., & Bernfield, M. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.7.797 · Cited by 426
Self-citationGlycosaminoglycans and the regulation of blood coagulation
Bourin, M. C., & Lindahl, U. (1993) · Biochemical Journal · doi:10.1042/bj2890313 · Cited by 419
A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact
Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., & Kriegler, M. (1990) · Cell · doi:10.1016/0092-8674(90)90158-b · Cited by 403
Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T. K., Rose-John, S., & Massagué, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11376 · Cited by 391
Gallo, R. L., Ono, M., Povsic, T., Page, C., Eriksson, E., Klagsbrun, M., & Bernfield, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11035 · Cited by 361
Self-citationEarp, H. S., Dawson, T. L., Li, X., & Yu, H. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694752 · Cited by 361
Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury.
Marikovsky, M., Breuing, K., Liu, P. Y., Eriksson, E., Higashiyama, S., Farber, P., Abraham, J., & Klagsbrun, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3889 · Cited by 325
Soluble cytokine receptors: their role in immunoregulation
Fernandez‐Botran, R. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1868981 · Cited by 283
Ehlers, M. R. W., & Riordan, J. F. (1991) · Biochemistry · doi:10.1021/bi00106a001 · Cited by 281
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.
Müllberg, J., Oberthür, W., Lottspeich, F., Mehl, E., Dittrich, E., Graeve, L., Heinrich, P. C., & Rose-John, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4958 · Cited by 269
Steinfeld, R., Van Den Berghe, H., & David, G. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.2.405 · Cited by 267
Goishi, K., Higashiyama, S., Klagsbrun, M., Nakano, N., Umata, T., Ishikawa, M., Mekada, E., & Taniguchi, N. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.8.967 · Cited by 266
ADAMs in Fertilization and Development
Wolfsberg, T. G., & White, J. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0313 · Cited by 253
A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
Müllberg, J., Durie, F. H., Otten-Evans, C., Alderson, M. R., Rose-John, S., Cosman, D., Black, R. A., & Mohler, K. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5198 · Cited by 249
Grinnell, F., Ho, C.-H., & Wysocki, A. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499839 · Cited by 245
Induced expression of syndecan in healing wounds.
Elenius, K., Vainio, S., Laato, M., Salmivirta, M., Thesleff, I., & Jalkanen, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.3.585 · Cited by 242
Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A., & Ware, C. F. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1205 · Cited by 231
Downing, J. R., Roussel, M. F., & Sherr, C. J. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.2890 · Cited by 227
Kato, M., Saunders, S., Nguyen, H., & Bernfield, M. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.5.559 · Cited by 217
Self-citationKato, M., Wang, H., Bernfield, M., Gallagher, J. T., & Turnbull, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32250-0 · Cited by 198
Self-citationKahn, J., Ingraham, R. H., Shirley, F., Migaki, G. I., & Kishimoto, T. K. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.461 · Cited by 196
Jalkanen, M., Nguyen, H., Rapraeger, A., Kurn, N., & Bernfield, M. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.976 · Cited by 185
Self-citationO'Connell, K. A., & Edidin, M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.521 · Cited by 177
Syndecans-1 and -4 Are Induced During Wound Repair of Neonatal but Not Fetal Skin
Gallo, R., Kim, C., Kokenyesi, R., Scott Adzick, N., & Bernfield, M. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12365571 · Cited by 175
Self-citationFine structure of heparan sulfate regulates syndecan-1 function and cell behavior.
Sanderson, R. D., Turnbull, J. E., Gallagher, J. T., & Lander, A. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36804-7 · Cited by 171
Jalkanen, M., Rapraeger, A., Saunders, S., & Bernfield, M. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.6.3087 · Cited by 168
Self-citationSyndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.
Leppä, S., Mali, M., Miettinen, H. M., & Jalkanen, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.3.932 · Cited by 161
Rapraeger, A. C., & Bernfield, M. R. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89237-7 · Cited by 155
Self-citationSanderson, R. D., & Bernfield, M. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9562 · Cited by 150
Self-citationTransforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.
Arribas, J., & Massagué, J. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.3.433 · Cited by 150
Drosophila syndecan: conservation of a cell-surface heparan sulfate proteoglycan.
Spring, J., Paine‐Saunders, S., Hynes, R. O., & Bernfield, M. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3334 · Cited by 148
Self-citationFeehan, C., Darłak, K., Kahn, J., Walcheck, B. K., Spatola, A. F., & Kishimoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.7019 · Cited by 137
Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor.
Pandiella, A., & Massagué, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67662-3 · Cited by 130
Pandiella, A., Bosenberg, M., Huang, E. J., Besmer, P., & Massagué, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35940-4 · Cited by 115
TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment.
Cabrera, N., Díaz-Rodríguez, E., Becker, E., Martín-Zanca, D., & Pandiella, A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.132.3.427 · Cited by 115
The Role of Syndecan-1 in Malignancies
Inki, P., & Jalkanen, M. (1996) · Annals of Medicine · doi:10.3109/07853899608999076 · Cited by 112
Syndecan-1, a Cell-Surface Proteoglycan, Changes in Size and Abundance when Keratinocytes Stratify
Sanderson, R. D., Hinkes, M. T., & Bernfield, M. R. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616103 · Cited by 104
Self-citationStructural requirements for inducible shedding of the p55 tumor necrosis factor receptor.
Brakebusch, C., Varfolomeev, E. E., Batkin, M., & Wallach, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31661-2 · Cited by 95
Juxtacrine cell signaling molecules
Bosenberg, M., & Massagué, J. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90032-l · Cited by 94
Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages
Yeaman, C. A., & Rapraeger, A. C. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.4.941 · Cited by 91
Leppä, S., Härkönen, P. L., & Jalkanen, M. (1991) · Cell Regulation · doi:10.1091/mbc.2.1.1 · Cited by 78
Activated release of membrane-anchored TGF-alpha in the absence of cytosol
Bosenberg, M., Pandiella, A., & Massagué, J. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.95 · Cited by 70
Leca, G., Mansur, S. E., & Bensussan, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1069 · Cited by 65
Levine, S. J., Logun, C., Chopra, D. P., Rhim, J.-H., & Shelhamer, J. H. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.14.3.8845176 · Cited by 40
Stein, J. A., & Rettenmier, C. W. (1991) · PubMed · Cited by 38
Deng, P., Rettenmier, C. W., Pattengale, P. K., Rettenmier, C. W., & Rettenmier, C. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16338 · Cited by 23
Troyer, D. A., Padilla, R. M., Smith, T., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88675-1 · Cited by 18
Anderson, R. G. W. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12668196 · Cited by 17
Cited by
Functions of Cell Surface Heparan Sulfate Proteoglycans
Bernfield, M., Götte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., & Zako, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.729 · Cited by 2,688
Self-citationLi, Q., Park, P. W., Wilson, C. L., & Parks, W. C. (2002) · Cell · doi:10.1016/s0092-8674(02)01079-6 · Cited by 752
Specificities of heparan sulphate proteoglycans in developmental processes
Perrimon, N., & Bernfield, M. (2000) · Nature · doi:10.1038/35008000 · Cited by 714
Self-citationJohnson, G. B., Brunn, G. J., Kodaira, Y., & Platt, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5233 · Cited by 648
Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins
Bandtlow, C. E., & Zimmermann, D. R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1267 · Cited by 632
Metadata
- Authors
- Subramanian, S. V., Fitzgerald, M. L., & Bernfield, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-06
- Volume
- 272
- Issue
- 23
- Pages
- 14713-14720
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2161625600
- Cited by
- 387
- References
- 63
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.